210 related articles for article (PubMed ID: 27090754)
1. Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.
Domogala A; Madrigal JA; Saudemont A
Cytotherapy; 2016 Jun; 18(6):754-9. PubMed ID: 27090754
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells differentiated in vitro from cord blood CD34
Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
[TBL] [Abstract][Full Text] [Related]
3. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
[TBL] [Abstract][Full Text] [Related]
4. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
5. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
9. Challenges of cancer therapy with natural killer cells.
Klingemann H
Cytotherapy; 2015 Mar; 17(3):245-9. PubMed ID: 25533934
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
[TBL] [Abstract][Full Text] [Related]
11. Natural killer-92 cells maintain cytotoxic activity after long-term cryopreservation in novel DMSO-free media.
Pasley S; Zylberberg C; Matosevic S
Immunol Lett; 2017 Dec; 192():35-41. PubMed ID: 28966059
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.
Biswas BK; Guru SA; Sumi MP; Jamatia E; Gupta RK; Lali P; Konar BC; Saxena A; Mir R
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1595-1605. PubMed ID: 32592353
[TBL] [Abstract][Full Text] [Related]
13. IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells.
Barao I; Hudig D; Ascensao JL
J Immunol; 2003 Jul; 171(2):683-90. PubMed ID: 12847234
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxic activity of ex vivo-differentiated human natural killer cells in the presence of HOXB4.
Nanbakhsh A; Pochon C; Amsellem S; Pittari G; Tejchman A; Bourhis JH; Chouaib S
J Immunother; 2014 Jun; 37(5):278-82. PubMed ID: 24810639
[TBL] [Abstract][Full Text] [Related]
15. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
[TBL] [Abstract][Full Text] [Related]
16. Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood are Cytotoxic Against Primary Breast Cancer Cells.
Nham T; Poznanski SM; Fan IY; Vahedi F; Shenouda MM; Lee AJ; Chew MV; Hogg RT; Lee DA; Ashkar AA
J Immunother; 2018; 41(2):64-72. PubMed ID: 29189387
[TBL] [Abstract][Full Text] [Related]
17. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.
Spanholtz J; Preijers F; Tordoir M; Trilsbeek C; Paardekooper J; de Witte T; Schaap N; Dolstra H
PLoS One; 2011; 6(6):e20740. PubMed ID: 21698239
[TBL] [Abstract][Full Text] [Related]
18. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
Luevano M; Daryouzeh M; Alnabhan R; Querol S; Khakoo S; Madrigal A; Saudemont A
Hum Immunol; 2012 Mar; 73(3):248-57. PubMed ID: 22234167
[TBL] [Abstract][Full Text] [Related]
19. Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells.
Kao IT; Yao CL; Kong ZL; Wu ML; Chuang TL; Hwang SM
Stem Cells Dev; 2007 Dec; 16(6):1043-51. PubMed ID: 17999637
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
Lin SJ; Kuo ML
Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
